Erratum: Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts (Cancer Chemotherapy and Pharmacology 45 (345- 349))

H. S. Friedman, R. C. Castellino, G. B. Elion, S. T. Keir, P. J. Houghton, S. P. Johnson, D. D. Bigner

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Number of pages1
JournalCancer chemotherapy and pharmacology
Volume46
Issue number1
StatePublished - 2000
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Toxicology
  • Pharmacology
  • Cancer Research
  • Pharmacology (medical)

Cite this